Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108301-108350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03603795
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
PHASE2Active, not recruiting
110 participants
Started: Oct 11, 2018 · Completed: Jul 30, 2026
1 condition2 sponsors15 locations
NCT05501587
Measures of Respiratory Health Registry
N/ARecruiting
1,000 participants
Started: Oct 11, 2018 · Completed: May 31, 2028
2 conditions1 sponsor1 location
NCT03418467
Risk Factors in Tachycardiomyopathy
N/AActive, not recruiting
60 participants
Started: Oct 11, 2018 · Completed: May 31, 2030
3 conditions1 sponsor1 location
NCT03068013
Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting
NARecruiting
171 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2024
3 conditions3 sponsors1 location
NCT03576417
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
PHASE3Active, not recruiting
680 participants
Started: Oct 10, 2018 · Completed: Sep 30, 2027
1 condition3 sponsors1 location
NCT03663790
Effects of Gait Retraining on Lower Extremity Biomechanics
NARecruiting
51 participants
Started: Oct 10, 2018 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT04099134
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
N/ARecruiting
5,000 participants
Started: Oct 10, 2018 · Completed: Oct 31, 2029
2 conditions1 sponsor1 location
NCT03539536
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
270 participants
Started: Oct 10, 2018 · Completed: Aug 31, 2026
1 condition1 sponsor252 locations
NCT04496362
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
PHASE4Recruiting
100 participants
Started: Oct 10, 2018 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT03715933
Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas
PHASE1Recruiting
321 participants
Started: Oct 10, 2018 · Completed: Dec 31, 2026
2 conditions1 sponsor34 locations
NCT04487587
A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer
PHASE2Active, not recruiting
79 participants
Started: Oct 9, 2018 · Completed: Mar 1, 2026
1 condition2 sponsors1 location
NCT03655912
Binocular Visual Therapy and Video Games for Amblyopia Treatment.
NARecruiting
60 participants
Started: Oct 9, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04864171
REASSURE-NIRS Registry
N/ARecruiting
2,000 participants
Started: Oct 9, 2018 · Completed: Mar 31, 2030
1 condition1 sponsor2 locations
NCT03673644
Impact of Glaucoma and Visual Field Loss on Life Space
N/AActive, not recruiting
88 participants
Started: Oct 9, 2018 · Completed: May 30, 2026
1 condition2 sponsors1 location
NCT06167928
Developing Allogeneic Musculoskeletal Therapies
N/ARecruiting
325 participants
Started: Oct 8, 2018 · Completed: Sep 1, 2037
1 condition10 sponsors1 location
NCT06360588
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
PHASE2Active, not recruiting
22 participants
Started: Oct 8, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03666416
Acute Effects of Exercise in College Students With ADHD
NARecruiting
48 participants
Started: Oct 8, 2018 · Completed: Dec 30, 2025
4 conditions1 sponsor1 location
NCT06040580
Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping?
N/AActive, not recruiting
150 participants
Started: Oct 8, 2018 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03710746
Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program
NAActive, not recruiting
406 participants
Started: Oct 8, 2018 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT06105619
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PHASE2/PHASE3Active, not recruiting
84 participants
Started: Oct 8, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03532737
Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
PHASE2Recruiting
50 participants
Started: Oct 7, 2018 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT03690388
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
PHASE3Active, not recruiting
187 participants
Started: Oct 5, 2018 · Completed: Jul 31, 2026
1 condition2 sponsors164 locations
NCT03908463
KOMATE Registry: Korean Multicenter Angioplasty Team
N/ARecruiting
20,000 participants
Started: Oct 5, 2018 · Completed: Apr 30, 2039
4 conditions1 sponsor1 location
NCT03554083
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma
PHASE2Active, not recruiting
59 participants
Started: Oct 5, 2018 · Completed: Nov 30, 2027
6 conditions1 sponsor3 locations
NCT03615326
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
PHASE3Active, not recruiting
738 participants
Started: Oct 5, 2018 · Completed: Nov 12, 2025
2 conditions1 sponsor192 locations
NCT01528189
Effect of High Dose Insulin on Infectious Complications Following Major Surgery
NARecruiting
460 participants
Started: Oct 5, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT03731130
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
N/ARecruiting
100 participants
Started: Oct 5, 2018 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT03737604
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
PHASE4Recruiting
200 participants
Started: Oct 4, 2018 · Completed: Jun 12, 2025
2 conditions1 sponsor1 location
NCT03126630
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Oct 4, 2018 · Completed: Sep 18, 2026
1 condition1 sponsor33 locations
NCT03715179
Observational Study of Ostomy Consumers
N/ARecruiting
5,000 participants
Started: Oct 4, 2018 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT04204135
The Course of Hip Flexion Weakness Following LLIF or ALIF
N/AEnrolling by invitation
22 participants
Started: Oct 4, 2018 · Completed: Nov 4, 2027
3 conditions1 sponsor1 location
NCT03715517
Spinal Anesthesia For Enhanced Recovery After Liver Surgery
NARecruiting
128 participants
Started: Oct 4, 2018 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT03609398
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
PHASE2Recruiting
500 participants
Started: Oct 4, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03589326
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
PHASE3Active, not recruiting
245 participants
Started: Oct 4, 2018 · Completed: Jul 31, 2027
1 condition1 sponsor92 locations
NCT03511118
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
N/ARecruiting
1,600 participants
Started: Oct 4, 2018 · Completed: Jul 31, 2027
2 conditions3 sponsors22 locations
NCT03759717
Molecular and Cellular Characterization of Skull Base Tumors
N/ARecruiting
4,000 participants
Started: Oct 3, 2018 · Completed: Oct 3, 2028
2 conditions1 sponsor1 location
NCT03705806
Palliative Thoracic ImmunoRT
N/ARecruiting
30 participants
Started: Oct 3, 2018 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT03543189
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
PHASE1/PHASE2Active, not recruiting
44 participants
Started: Oct 3, 2018 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT03630055
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
PHASE3Recruiting
1,800 participants
Started: Oct 3, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT04603209
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
N/ARecruiting
1,000 participants
Started: Oct 3, 2018 · Completed: Oct 3, 2028
3 conditions1 sponsor1 location
NCT03500107
Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial
NARecruiting
40 participants
Started: Oct 2, 2018 · Completed: Dec 20, 2025
1 condition3 sponsors1 location
NCT03531099
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
PHASE3Active, not recruiting
108 participants
Started: Oct 2, 2018 · Completed: Oct 2, 2026
1 condition1 sponsor14 locations
NCT03762499
Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.
NARecruiting
750 participants
Started: Oct 2, 2018 · Completed: Oct 2, 2028
1 condition1 sponsor1 location
NCT03511625
The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis
PHASE3Active, not recruiting
6 participants
Started: Oct 2, 2018 · Completed: Dec 3, 2024
1 condition2 sponsors1 location
NCT03529019
Nutrition in Patient With Critical Limb Ischemia
EARLY_PHASE1Recruiting
30 participants
Started: Oct 2, 2018 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT03857594
Integrative Sequencing in Germline and Hereditary Tumours
N/AActive, not recruiting
10 participants
Started: Oct 2, 2018 · Completed: Sep 30, 2025
4 conditions1 sponsor1 location
NCT03386045
Optimal Prostate Study
NARecruiting
214 participants
Started: Oct 2, 2018 · Completed: Aug 1, 2028
1 condition1 sponsor1 location
NCT03595683
Pembrolizumab and EDP1503 in Advanced Melanoma
PHASE2Active, not recruiting
8 participants
Started: Oct 2, 2018 · Completed: Nov 2, 2027
2 conditions3 sponsors1 location
NCT03709199
Long Term Follow up of Children Enrolled in the REDvent Study
N/AActive, not recruiting
176 participants
Started: Oct 1, 2018 · Completed: May 1, 2026
5 conditions1 sponsor1 location
NCT05817734
Human Phenotype Project Study Protocol
N/ARecruiting
30,000 participants
Started: Oct 1, 2018 · Completed: Dec 31, 2045
1 condition1 sponsor1 location